These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 205112)

  • 1. Solid tumor models for the assessment of different treatment modalities: VI: Perturbations in the kinetics of tumor and host organ cellular regulation demonstrated by single and combined experimental therapy.
    Looney WB; Hopkins HA; Trefil JS
    Adv Exp Med Biol; 1977 May 22-24; 92():677-757. PubMed ID: 205112
    [No Abstract]   [Full Text] [Related]  

  • 2. Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil.
    Looney WB; Schaffner JG; Trefil JS; Kovacs CJ; Hopkins HA
    Br J Cancer; 1976 Sep; 34(3):254-61. PubMed ID: 184808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy.
    Looney WB; Trefil JS; Hopkins HA; Kovacs CJ; Ritenour R; Schaffner JG
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1983-7. PubMed ID: 194245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid tumor models for the assessment of different treatment modalities: systematics of response to radiotherapy and chemotherapy.
    Looney WB; Trefil JS; Schaffner JG; Kovacs CJ; Hopkins HA
    Proc Natl Acad Sci U S A; 1976 Mar; 73(3):818-22. PubMed ID: 176656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled antibody in the treatment of primary and metastatic liver malignancies.
    Order SE; Klein JL; Leichner PK; Ettinger DS; Kopher K; Finney K; Surdyke M; Leibel SA
    Recent Results Cancer Res; 1986; 100():307-14. PubMed ID: 3016844
    [No Abstract]   [Full Text] [Related]  

  • 6. Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.
    Looney WB; Macleod MS; Hopkins HA
    Br J Cancer; 1978 May; 37(5):841-8. PubMed ID: 207298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronization of host and tumor responses for sequential therapy in experimental solid tumors.
    Hopkins HA; Looney WB
    Antibiot Chemother (1971); 1978; 23():135-47. PubMed ID: 206197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined effect of x-radiation and radical reaction inhibitors on the tumor and body of the tumor host].
    Burlakova EB; Gaintseva VD; Pal'mina NP
    Dokl Akad Nauk SSSR; 1973 Dec; 213(6):1451-3. PubMed ID: 4360438
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of trace and minor elements in the solid tumor model 3924A hepatoma before and after treatment with t-fluorouracil.
    Brookhart W; Allen R; Looney W; Hopkins H; Kovacs C; Morris H
    Life Sci; 1975 Jul; 17(2):233-40. PubMed ID: 169448
    [No Abstract]   [Full Text] [Related]  

  • 10. [Selective chemotherapy of hepatocellular carcinomas].
    Keppler D; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
    [No Abstract]   [Full Text] [Related]  

  • 11. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 12. The biologic basis of malignant brain tumor therapy.
    Kirsch WM; Van Buskirk JJ; Schulz DW; Tabuchi K
    Adv Neurol; 1976; 15():301-13. PubMed ID: 180778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non-surgical therapy for hepatocellular carcinoma].
    Ye SL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):558-60. PubMed ID: 16867289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of intra-arterial infusion chemotherapy with radiation therapy for advanced hepatocellular carcinoma].
    Abe K; Sugata F; Takizawa K; Yoshiba M; Takagi T; Kuniyasu Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1474-7. PubMed ID: 1326911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in the treatment of hepatocellular carcinoma.
    Roh MS
    Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical treatment of hepatocellular carcinoma.
    Nerenstone S; Friedman M
    Gastroenterol Clin North Am; 1987 Dec; 16(4):603-12. PubMed ID: 2831153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma.
    Cochrane AM; Murray-Lyon IM; Brinkley DM; Williams R
    Cancer; 1977 Aug; 40(2):609-14. PubMed ID: 196734
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of guinea pig cancer with BCG.
    Zbar B; Rapp HJ
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1532-40. PubMed ID: 4371315
    [No Abstract]   [Full Text] [Related]  

  • 20. Polyamine depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924A hepatomas after 5-fluorouracil administration.
    Russell DH; Looney WB; Kovacs CJ; Hopkins HA; Marton LJ; LeGendre SM; Morris HP
    Cancer Res; 1974 Sep; 34(9):2382-5. PubMed ID: 4367291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.